Clinical implications of high NQO1 expression in breast cancers

Yang� Yang, Yan Zhang, Qunying Wu, +4

Journal of Experimental & Clinical Cancer Research

High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma

Junjie Piao, Lianhua Zhu, Jie Sun, +4

Gene

OncologyPancreatic CancerMedicineHigh ExpressionPathology +7

The NQO1/p53/SREBP1 axis promotes hepatocellular carcinoma progression and metastasis by regulating Snail stability

Xinyue Wang, Ying Liu, Anna Han, +6

Oncogene

Cancer ResearchSnail StabilityNqo1/p53/srebp1 AxisLiver PhysiologyMedicine +9

PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer

Liyan Chen, Tiefeng Jin, Kun Zhu, +4

Oncotarget

Molecule-targeted TherapyOncologyBreast OncologyMedicineEffective Drug Combinations +12

Ezrin promotes breast cancer progression by modulating AKT signals

Nan Li, Jienan Kong, Zhenhua Lin, +5

British Journal of Cancer

DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer

Yang Yang, Meihua Gao, Zhenhua Lin, +5

Oncotarget

The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast

Haidan Jin, Meiying Ji, Liyan Chen, +4

Journal of Experimental & Clinical Cancer Research

Inhibition of Glycogen Synthase Kinase 3β Ameliorates D-GalN/LPS-Induced Liver Injury by Reducing Endoplasmic Reticulum Stress-Triggered Apoptosis

Liyan Chen, Feng Ren, Haiyang Zhang, +9

PLoS ONE

Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition

Jienan Kong, Chunchan Di, Junjie Piao, +5

Oncotarget

Epithelial-mesenchymal TransitionAdvanced Cervical CancerCervical Cancer ProgressionCervical CancerCell Regulation +12

Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma

Ming Xu, Tiefeng Jin, Liyan Chen, +4

Gene